Roles for TLR7, TLR8, and TLR9 in the pathology of such diseases are now well established in humans and mice, and suppression of TLR activation is being pursued therapeutically as a treatment for several autoimmune diseases (Lind et al., 2022; McWhirter and Jefferies, 2020). This evidence concerns the gene TLR7 and autoimmune disease.